Login / Signup

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.

Nabil NoureddinDaniel Q HuangRicki BettencourtHarris SiddiqiAbdul M MajzoubTarek NayfehNobuharu TamakiNamiki IzumiHirokazu TakahashiRamazan IdilmanMesut GumussoyDigdem Kuru OzAyse ErdenTolga GidenerAlina M AllenVeeral AjmeraStephen Caldwell
Published in: Alimentary pharmacology & therapeutics (2024)
The most common first liver-related event in MASLD patients is ascites. The median survival from the first hepatic decompensation to either death or transplantation is 2 years.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • oxidative stress
  • stem cells
  • mesenchymal stem cells
  • patient reported